Boston Scientific Receives FDA Approval for VICI VENOUS STENT System
Posted on May 06, 2019 by Medtech[y] Staff
The FDA has approved Boston Scientific's VICI VENOUS STENT System for the treatment of iliofemoral venous obstructive disease. The stent system received CE Mark in 2013 and came over to Boston Scientific in their acquisition of VENITI.
The approval of the VICI stent was based on data from the VIRTUS study, which is a prospective, multi-center, single-arm study with 170 patients and evaluated the VICI stent in relation to pre-defined objective performance goals in patients with a clinically significant obstruction in the illiofemoral venous outflow tract. It successfully met its primary safety and effectiveness endpoints.
"For those suffering from venous obstructive disease, their quality of life may suffer without treatment options optimized for the disease," said Dr. Mahmood Razavi, St. Joseph Hospital, Orange, California. "With the approval of the VICI stent, clinicians now have access to a stent that was purposely developed and engineered to resist the vessel compression and anatomical tortuosity commonly found within the iliofemoral venous system, enabling our ability to deliver best outcomes for our patients."
Are you a recruiter or company looking to fill a Medical Sales opening, including the medical device or biotech industries? If so, checkout Medtechy Jobs and create a free employer account or a free candidate account. All of our jobs are strategically distributed to our diverse following of experienced and those new to the industry. Multi-pack jobs start at $100.
We are also excited to launch Medtechy Deals, our new store which sources deals on gadgets, everyday carry essentials and online courses for employees in the healthcare industry!
Please follow us on Facebook, Twitter, and LinkedIn for the latest medical technology news, medical device/biotech company intel and career opportunities. You can also sign up for our monthly newsletter.